SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-190209
Filing Date
2020-07-09
Accepted
2020-07-09 10:27:30
Documents
14
Period of Report
2020-07-09

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d937891d6k.htm 6-K 14006
2 EX-4.1 d937891dex41.htm EX-4.1 353351
3 EX-4.2 d937891dex42.htm EX-4.2 52414
4 EX-4.3 d937891dex43.htm EX-4.3 52645
5 EX-4.4 d937891dex44.htm EX-4.4 53012
6 EX-4.5 d937891dex45.htm EX-4.5 52742
7 EX-4.6 d937891dex46.htm EX-4.6 50957
8 EX-4.7 d937891dex47.htm EX-4.7 51025
9 EX-4.8 d937891dex48.htm EX-4.8 50400
10 EX-4.9 d937891dex49.htm EX-4.9 50698
11 EX-5.1 d937891dex51.htm EX-5.1 11066
12 EX-5.2 d937891dex52.htm EX-5.2 10167
13 EX-5.3 d937891dex53.htm EX-5.3 23061
14 EX-5.4 d937891dex54.htm EX-5.4 23025
  Complete submission text file 0001193125-20-190209.txt   849528
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 201019856
SIC: 2834 Pharmaceutical Preparations